tradingkey.logo

Pointing to US investments, Novartis expects no impact from new 100% tariff

ReutersSep 26, 2025 10:07 AM

- Switzerland's Novartis NOVN.S said on Friday that a new U.S. pharmaceutical tariff "should have no impact" on its activities, pointing to a $23 billion investment in U.S. infrastructure and the construction of new sites in the country.

"We are working to ensure that all major Novartis medicines for U.S. patients are manufactured in the U.S.," the company said in a statement. "Against this backdrop, the announced 100% tariff should have no impact on Novartis."

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI